Concepedia

Publication | Open Access

Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial

DOIFull Paper Access

27

Citations

22

References

2023

Year

Yong Huo, Beijian Chen, Qiufang Lian, Shuqing Wang, Lu Liu, Di Lu, Yanling Qu, Guanzhong Zheng, Lipeng Li, Yuan Ji,
The Lancet Regional Health - Western Pacific

Abstract

This study was sponsored by Innovent Biologics, Inc.

References

YearCitations

Page 1